"Established on 8th December 1994 by a group of dedicated doctors, Wesley Medical Research is Queensland’s second-oldest medical research institute. For the past 26 years, Wesley Medical Research has continued to push the frontiers of medicine, delivering real impact to patients while contributing to knowledge globally. As the official research organisation for UnitingCare, the research activity undertaken by Wesley Medical Research aims to span all UnitingCare hospitals including The Wesley Hospital, St Andrew’s War Memorial Hospital, Buderim Private Hospital at the Sunshine Coast, and St Stephen’s Hospital at Hervey Bay."

During the past decade, Wesley Medical Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wesley Medical Research" #1 sponsor was "Genzyme, a Sanofi Company" with 2 trials, followed by "Boston Scientific Corporation" with 1 trials sponsored, "Cellxpert Biotechnology Corp." with 1 trials sponsored, "Cogentus Pharmaceuticals" with 1 trials sponsored and "Mitsubishi Tanabe Pharma America Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wesley Medical Research" #1 collaborator was "Bayer" with 2 trials as a collaborator and "Medigen Biotechnology Corporation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Wesley Medical Research" are "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Acute Coronary Syndrome" (1 trials), "Cardiac Arrhythmias" (1 trials), "Chronic Obstructive Pulmonary Disease" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Wesley Medical Research" in a lesser frequency.

Most popular intervention types in "Wesley Medical Research" are "Drug" (4 trials), "Biological" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Interferon beta-1a" (2 trials), "Alemtuzumab" (1 trials), "Alemtuzumab 12 mg" (1 trials), "Alemtuzumab 24 mg" (1 trials) and "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wesley Medical Research" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Wesley Medical Research". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Wesley Medical Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Wesley Medical Research, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".